Toll‐like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons

Microglia are rapidly activated in the central nervous system (CNS) in response to a variety of injuries, including inflammation, trauma, and stroke. In addition to modulation of the innate immune response, a key function of microglia is the phagocytosis of dying cells and cellular debris, which can facilitate recovery. Despite emerging evidence that axonal debris can pose a barrier to regeneration of new axons in the CNS, little is known of the cellular and molecular mechanisms that underlie clearance of degenerating CNS axons. We utilize a custom micropatterned microfluidic system that enables robust microglial‐axon co‐culture to explore the role of Toll‐like receptors (TLRs) in microglial phagocytosis of degenerating axons. We find that pharmacologic and genetic disruption of TLR4 blocks induction of the Type‐1 interferon response and inhibits phagocytosis of axon debris in vitro. Moreover, TLR4‐dependent microglial clearance of unmyelinated axon debris facilitates axon outgrowth. In vivo, microglial phagocytosis of CNS axons undergoing Wallerian degeneration in a dorsal root axotomy model is impaired in adult mice in which TLR4 has been deleted. Since purinergic receptors can influence TLR4‐mediated signaling, we also explored a role for the microglia P2 receptors and found that the P2X7R contributes to microglial clearance of degenerating axons. Overall, we identify TLR4 as a key player in axonal debris clearance by microglia, thus creating a more permissive environment for axonal outgrowth. Our findings have significant implications for the development of protective and regenerative strategies for the many inflammatory, traumatic, and neurodegenerative conditions characterized by CNS axon degeneration. GLIA 2014;62:1982–1991

[1]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[2]  U. Hanisch,et al.  Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin , 2012, Journal of Neuroinflammation.

[3]  Labchan Rajbhandari,et al.  Toll/Interleukin-1 Receptor Domain-Containing Adapter Inducing Interferon-β Mediates Microglial Phagocytosis of Degenerating Axons , 2012, The Journal of Neuroscience.

[4]  M. Gavala,et al.  Nucleotide receptor P2RX7 stimulation enhances LPS‐induced interferon‐β production in murine macrophages , 2013, Journal of leukocyte biology.

[5]  P. Bertics,et al.  Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. , 2004, American journal of physiology. Cell physiology.

[6]  B. Melchior,et al.  Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo , 2009, Journal of neurochemistry.

[7]  J. Boeynaems,et al.  Nucleotide receptor P2Y4 , 2005 .

[8]  J. Koenigsknecht-Talboo,et al.  Regulation of Microglial Phagocytosis and Inflammatory Gene Expression by Gas6 Acting on the Axl/Mer Family of Tyrosine Kinases , 2008, Journal of Neuroimmune Pharmacology.

[9]  S. Nagata,et al.  Identification of Tim4 as a phosphatidylserine receptor , 2007, Nature.

[10]  O. Hazeki,et al.  A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling , 2006, Molecular Pharmacology.

[11]  S. Rivest,et al.  Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury , 2007, The Journal of Neuroscience.

[12]  S. Lehnardt,et al.  Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.

[13]  R. Franklin,et al.  Enhancing Central Nervous System Remyelination in Multiple Sclerosis , 2005, Neuron.

[14]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[15]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[16]  A. Mildner,et al.  Toll-Like Receptor Prestimulation Increases Phagocytosis of Escherichia coli DH5α and Escherichia coli K1 Strains by Murine Microglial Cells , 2008, Infection and Immunity.

[17]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[18]  D. Kumararatne,et al.  ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. , 2002, Journal of immunology.

[19]  Susumu Mori,et al.  Diffusion Tensor Magnetic Resonance Imaging of Wallerian Degeneration in Rat Spinal Cord after Dorsal Root Axotomy , 2009, The Journal of Neuroscience.

[20]  P. Gebicke-haerter,et al.  Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Tolkovsky,et al.  Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death , 2011, The Journal of Immunology.

[22]  S. Duan,et al.  P2X7 receptors: Properties and relevance to CNS function , 2006, Glia.

[23]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[24]  H. Neumann,et al.  Microglial activatory (immunoreceptor tyrosine‐based activation motif)‐ and inhibitory (immunoreceptor tyrosine‐based inhibition motif)‐signaling receptors for recognition of the neuronal glycocalyx , 2013, Glia.

[25]  E. Pålsson-McDermott,et al.  Building an immune system from nine domains. , 2007, Biochemical Society transactions.

[26]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[27]  J W Griffin,et al.  Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  S. Grinstein,et al.  Activation of P2X7 Receptor by ATP Plays an Important Role in Regulating Inflammatory Responses during Acute Viral Infection , 2012, PloS one.

[29]  G. Landreth,et al.  CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation , 2009, The Journal of Neuroscience.

[30]  T. Yamashita,et al.  Engulfment of Axon Debris by Microglia Requires p38 MAPK Activity* , 2009, The Journal of Biological Chemistry.

[31]  S. Akira,et al.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.

[32]  Melissa D. Laird,et al.  High mobility group box protein‐1 promotes cerebral edema after traumatic brain injury via activation of toll‐like receptor 4 , 2014, Glia.

[33]  F. Abdul-Karim,et al.  Activation of P2X7-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice , 2009, BMC Cancer.

[34]  Ka Wan Li,et al.  Differential Transport and Local Translation of Cytoskeletal, Injury-Response, and Neurodegeneration Protein mRNAs in Axons , 2005, The Journal of Neuroscience.

[35]  Nitish Thakor,et al.  Circular compartmentalized microfluidic platform: Study of axon-glia interactions. , 2010, Lab on a chip.

[36]  S. Hammerschmidt,et al.  Toll-Like Receptor Stimulation Enhances Phagocytosis and Intracellular Killing of Nonencapsulated and Encapsulated Streptococcus pneumoniae by Murine Microglia , 2009, Infection and Immunity.

[37]  R. Unwin,et al.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases , 2011, Expert opinion on investigational drugs.

[38]  W. Poewe,et al.  Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons. , 2011, The American journal of pathology.

[39]  M. Freeman,et al.  Distinct molecular pathways mediate glial activation and engulfment of axonal debris after axotomy , 2012, Nature Neuroscience.

[40]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[41]  R. Nau,et al.  Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells , 2013, Journal of Neuroinflammation.

[42]  J. Griffin,et al.  Delayed Macrophage Responses and Myelin Clearance during Wallerian Degeneration in the Central Nervous System: The Dorsal Radiculotomy Model , 1994, Experimental Neurology.

[43]  P. Gebicke-haerter,et al.  Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  M. Freeman,et al.  Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling , 2008, Nature.

[45]  R. Coffman,et al.  Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists , 2007, Nature Medicine.

[46]  C. J. Crosby,et al.  The Fate of Axonal Debris in Wallerian Degeneration of Rat Optic and Sciatic Nerves: Electron Microscopy and Immunofluorescence Studies with Neurofilament Antisera , 1981, Journal of neuropathology and experimental neurology.

[47]  J. Sloane,et al.  A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors , 2010, NeuroMolecular Medicine.

[48]  H. Neumann,et al.  Microglial clearance function in health and disease , 2009, Neuroscience.